Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis

Clinical trial NCT03536559 · TERMINATED

Trial details

NCT number: NCT03536559
Sponsor: Clene Nanomedicine
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis Optic Neuropathy Optic; Neuritis, With Demyelination

Start date: 2018-11-23
Primary completion: 2022-04-27
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.